|
1) Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol. 1964; 10: 333-59
|
|
|
|
2) Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996; 47: 1-9
|
|
|
|
|
|
3) Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009; 8: 270-9
|
|
|
|
|
4) Tsuboi Y, Slowinski J, Josephs KA, et al. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. 2003; 60: 1766-9
|
|
|
|
|
|
5) Paviour DC, Price SL, Stevens JM, et al. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. 2005; 64: 675-9
|
|
|
|
|
|
6) Nicoletti G, Tonon, C, Lodi R, et al. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinsonʼs disease. Mov Disord. 2008; 23: 2370-6
|
|
|
|
|
|
7) Knake S, Belke M, Menzler K, et al. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord. 2010; 25: 1232-8
|
|
|
|
|
|
8) Piao YS, Hayashi S, Wakabayashi K, et al. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2002; 103: 469-74
|
|
|
|
|
|
9) Arai K, Braak E, De Vos RAI, et al. Mossy fiber involvement in progressive supranucelar palsy. Acta Neuropathol. 1999; 98: 341-4
|
|
|
|
|
|
10) Kanazawa M, Shimohata T, Toyoshima Y, et al. Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord. 2009; 24: 1312-8
|
|
|
|
|
|
11) 饗場郁子, 斎藤由扶子, 安田武司, 他. 小脳性運動失調の目立った進行性核上性麻痺の1剖検例. 神経内科. 2002; 56: 230-3
|
|
|
|
|
12) 内海裕也, 阿部一博, 吉井 治, 他. 歩行障害と痴呆を呈した71歳女性. 脳神経. 1995; 47: 295-307
|
|
|
|
|
|
13) Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardsonʼs syndrome and PSP-parkinsonism. Brain. 2005; 128: 1247-58
|
|
|
|
|
|
14) Jellinger KA. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegenerative Dis. 2008; 5: 339-46
|
|
|
|
|
|
15) Sakamoto R, Tsuchiya K, Mimura M. Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases. Neuropathology. 2010; 30: 24-35
|
|
|
|
|
|
16) Shirota Y, Hamada M, Hanajima R, et al. Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study. Mov Disord. 2010; 25: 2413-9
|
|
|
|
|
|
17) Ugawa Y, Uesaka Y, Terao Y, et al. Magnetic stimulation over the cerebellum in humans. Ann Neurol. 1995; 37: 703-13
|
|
|
|
|
|
18) Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-paikinsonism from Richardsonʼs syndrome. Brain. 2007; 130: 1566-76
|
|
|
|
|
|
19) Williams DR, Lees AJ. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism？ Mov Disord. 2010; 25: 357-62
|
|
|
|
|